Nav: Home

Ten Reaxys® Ph.D. prize candidates selected to present at symposium in London

August 04, 2016

Philadelphia, PA, August 4, 2016 - Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced that 10 Reaxys PhD Prize candidates have been short-listed from the 45 chemists nominated in May. The candidates will present at the annual Reaxys Prize Symposium to be held in conjunction with the New Scientist Live festival in London from September 22-23.

The oral presentation in September will be the last step in the reviewing process of the Reaxys PhD Prize, an international award that recognizes and rewards the most innovative research produced by chemistry's rising stars. The jury, which consists of members of the Reaxys Advisory Board, will chose three winners, who will be announced at the Symposium dinner on September 23.

The 10 shortlisted candidates are:
  • Nickolas Anderson from the Bart group, Purdue University - West Lafayette
  • Chuyang Cheng from the Stoddart group, Northwestern University
  • Lauren Doyle from the Piers group, University of Calgary
  • Pascal Ellerbrock from the Trauner group, Ludwig-Maximilian University of Munich
  • Sebastian Grundner from the Lercher group, Technical University of Munich
  • Jamie Hicks from the Jones group, Monash University
  • Jiheong Kang from the Aida group, University of Tokyo
  • Jarad Mason from the Long group, University of California Berkeley
  • Yusuke Masuda from the Murakami group, Kyoto University
  • Alison Wendlandt from the Stahl group, University of Wisconsin - Madison

All of the original 45 finalists from this year's prize have been invited to attend the Symposium and present their work during a poster session. The jury's review criteria include the originality, innovation, applicability, importance, and rigor of the reported research.

Since its introduction in 2010, the Reaxys PhD Prize has received more than 3,000 submissions, from nearly 650 universities worldwide. The Prize aims to not only nurture advances in chemistry by giving talented young chemists who have produced groundbreaking research the recognition they deserve, but also present them with opportunities to extend their network, unlock new sources of inspiration and share knowledge.

Read more about the Reaxys PhD Prize, this year's 10 short-listed candidates and the Symposium.
About Reaxys

Reaxys empowers chemistry research and development by providing structure, property and reaction data, experimental procedures and literature. It is designed to support early drug discovery, education, material selection and synthesis planning; its capabilities include data export and integration to enable harmonized analysis of in-house and external data. Reaxys improves R&D productivity by delivering the facts the way chemists need them.

Reaxys is a trademark of RELX Intellectual Properties SA, used under license.

About Elsevier

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions -- among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKey -- and publishes over 2,500 journals, including The Lancet and Cell, and more than 35,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group, a world-leading provider of information and analytics for professional and business customers across industries.


Related Candidates Articles:

PolyU develops a new class of antibiotic candidates for fighting against superbugs
The Hong Kong Polytechnic University (PolyU) has developed a new class of antibiotic drug candidates which has high potential to be developed into a new generation of antibiotics fighting against multi-drug resistant superbugs including methicillin-resistant Staphylococcus aureus (MRSA).
Voters really want presidential candidates to talk more about science
A large majority of Iowans (74 percent) say it is important for the presidential candidates to talk about how science and scientific research will affect their policymaking decisions, but only 22 percent recall them discussing science issues during the past two months.
When considering presidential candidates, age is just a number
A new white paper shows there is no such thing as being too old to be president.
New methods to identify Alzheimer's drug candidates with anti-aging properties
Old age is the greatest risk factor for many diseases, including Alzheimer's disease (AD) and cancer.
Tracking down microRNA candidates that can contribute to disease
A novel computational tool called ADmiRE extensively annotates human microRNA variants to determine which ones are likely to contribute to or cause diseases.
More Candidates News and Candidates Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Erasing The Stigma
Many of us either cope with mental illness or know someone who does. But we still have a hard time talking about it. This hour, TED speakers explore ways to push past — and even erase — the stigma. Guests include musician and comedian Jordan Raskopoulos, neuroscientist and psychiatrist Thomas Insel, psychiatrist Dixon Chibanda, anxiety and depression researcher Olivia Remes, and entrepreneur Sangu Delle.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...